| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
|---|
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium adolescentis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium breve co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [14] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium longum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bifidobacterium ruminatum co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella aerofaciens co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Loxapine succinate |
Click to Show/Hide the Detail |
| Drug ID |
DR0989
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella aerofaciens co-metabolize the drug Loxapine succinate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella aerofaciens co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella aerofaciens co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella aerofaciens co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Collinsella intestinalis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Corynebacterium amycolatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Corynebacterium amycolatum co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [29] |
| Corynebacterium jeikeium (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Corynebacterium jeikeium co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [29] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 17 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [32] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mefloquine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1016
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Mefloquine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eggerthella lenta co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Gardnerella vaginalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tenofovir alafenamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1552
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Gardnerella vaginalis co-metabolize the drug Tenofovir alafenamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [37], [38] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [40] |
| Vitamin D |
Click to Show/Hide the Detail |
| Drug ID |
DR1700
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Mycobacterium tuberculosis co-metabolize the drug Vitamin D, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [42] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [44] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[45], [46], [47] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[48], [49], [46] |
| Streptomyces griseus (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Streptomyces griseus co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [51], [52] |
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Streptomyces griseus co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [54] |
| Bacteria: Bacteroidetes |
|---|
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 20 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Ziprasidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1732
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Alistipes indistinctus co-metabolize the drug Ziprasidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [2] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| EPX-100 |
Click to Show/Hide the Detail |
| Drug ID |
DR2274
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug EPX-100, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides cellulosilyticus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 21 Drugs Metabolized
|
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[67], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[68], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides coprophilus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 51 Drugs Metabolized
|
| Alfuzosin hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0063
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Alfuzosin hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[71], [2] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bezafibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0209
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Bezafibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[45], [75] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[76], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[80], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides dorei co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 27 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides eggerthii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides finegoldii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 66 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Bezafibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0209
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Bezafibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Bicalutamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0210
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Bicalutamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[86], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clindamycin |
Click to Show/Hide the Detail |
| Drug ID |
DR0340
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Clindamycin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[87], [88] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[67], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[68], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [91], [92] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Rosuvastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR1445
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Rosuvastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[93], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tadalafil |
Click to Show/Hide the Detail |
| Drug ID |
DR1525
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Tadalafil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[94], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Tranilast |
Click to Show/Hide the Detail |
| Drug ID |
DR1628
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Tranilast, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[95], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides fragilis co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides intestinalis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides oleiciplenus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides oleiciplenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [96] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 20 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[68], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides ovatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 48 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[68], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[80], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides sartorii co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 21 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides stercoris co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 43 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[67], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Galantamine hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0761
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Galantamine hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[68], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Irinotecan hydrochloride, and Bacteroides thetaiotaomicron further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[98], [99] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [14] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tadalafil |
Click to Show/Hide the Detail |
| Drug ID |
DR1525
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Tadalafil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[94], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Tranilast |
Click to Show/Hide the Detail |
| Drug ID |
DR1628
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Tranilast, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides thetaiotaomicron co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[67], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Irinotecan hydrochloride, and Bacteroides uniformis further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[98], [99] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides uniformis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 45 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Bezafibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0209
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Bezafibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[100], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[80], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[95], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Ziprasidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1732
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides vulgatus co-metabolize the drug Ziprasidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 45 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[80], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides xylanisolvens co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 48 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Bezafibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0209
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Bezafibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Repaglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1404
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Repaglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Odoribacter splanchnicus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 30 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| OPC-12759 |
Click to Show/Hide the Detail |
| Drug ID |
DR1399
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug OPC-12759, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[80], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides distasonis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[84], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 28 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[101], [102] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides johnsonii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 26 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bezafibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0209
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Bezafibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Losartan potassium |
Click to Show/Hide the Detail |
| Drug ID |
DR0984
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Parabacteroides merdae co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Porphyromonas gingivalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Clindamycin |
Click to Show/Hide the Detail |
| Drug ID |
DR0340
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Porphyromonas gingivalis co-metabolize the drug Clindamycin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[87], [88] |
| Prevotella buccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella buccae co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[101], [103], [104] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 18 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Naloxone |
Click to Show/Hide the Detail |
| Drug ID |
DR1127
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Naloxone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[70], [2] |
| Nitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR1166
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Nitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[105], [106] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella copri co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Prevotella veroralis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Prevotella veroralis co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [108] |
| Bacteria: Firmicutes |
|---|
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerobutyricum hallii co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerococcus hydrogenalis co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[100], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerostipes hadrus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[109], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Anaerotruncus colihominis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[110], [111] |
| Benzyloxyresorufin |
Click to Show/Hide the Detail |
| Drug ID |
DR2451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Benzyloxyresorufin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[112], [111] |
| Buspirone |
Click to Show/Hide the Detail |
| Drug ID |
DR0248
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Buspirone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[113], [111], [114] |
| Chlorzoxazone |
Click to Show/Hide the Detail |
| Drug ID |
DR0312
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Chlorzoxazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [115], [111] |
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [111] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[45], [116] |
| GEA-6414 |
Click to Show/Hide the Detail |
| Drug ID |
DR1613
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug GEA-6414, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [116] |
| Nifedipine |
Click to Show/Hide the Detail |
| Drug ID |
DR1152
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Nifedipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[117], [115], [111] |
| Progesterone |
Click to Show/Hide the Detail |
| Drug ID |
DR1346
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[118], [114] |
| Propranolol hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1367
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[119], [114] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[48], [114], [120] |
| Bacillus pumilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Gemfibrozil |
Click to Show/Hide the Detail |
| Drug ID |
DR0766
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacillus pumilus co-metabolize the drug Gemfibrozil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [121] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Bacteroides pectinophilus co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 49 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[122], [2] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| AY-27,255 |
Click to Show/Hide the Detail |
| Drug ID |
DR1697
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug AY-27,255, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[123], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[76], [2] |
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| EPX-100 |
Click to Show/Hide the Detail |
| Drug ID |
DR2274
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug EPX-100, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[124], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Orphenadrine citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR2438
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Orphenadrine citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[125], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Rosuvastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR1445
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Rosuvastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[93], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia hansenii co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Blautia luti co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[110], [126] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridioides difficile co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 49 Drugs Metabolized
|
| Anastrozole |
Click to Show/Hide the Detail |
| Drug ID |
DR0113
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[122], [2] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| AY-27,255 |
Click to Show/Hide the Detail |
| Drug ID |
DR1697
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug AY-27,255, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Colchicine |
Click to Show/Hide the Detail |
| Drug ID |
DR0372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Colchicine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [2] |
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[123], [2] |
| Cyproterone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0396
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Cyproterone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[73], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Digoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0498
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Digoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[76], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Indapamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0868
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Indapamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[127], [2] |
| Isradipine |
Click to Show/Hide the Detail |
| Drug ID |
DR0891
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Isradipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mebendazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1005
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Mebendazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mifepristone |
Click to Show/Hide the Detail |
| Drug ID |
DR1091
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Mifepristone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[79], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[82], [2] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[124], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Paroxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1245
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Paroxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[128], [2] |
| Pergolide mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR2412
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Pergolide mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[129], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[109], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium botulinum co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[85], [2] |
| Clostridium leptum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Nitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR1166
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium leptum co-metabolize the drug Nitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[105], [130] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium leptum co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[131], [132] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Irinotecan hydrochloride, and Clostridium perfringens further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[98], [133] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [14] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [134] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [134] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium perfringens co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[131], [132] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium scindens co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium spiroforme co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 22 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[135], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Digitoxin |
Click to Show/Hide the Detail |
| Drug ID |
DR0497
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Digitoxin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [2] |
| Ezetimibe |
Click to Show/Hide the Detail |
| Drug ID |
DR0677
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[89], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Prednisone |
Click to Show/Hide the Detail |
| Drug ID |
DR1334
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Prednisone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[81], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[131], [132] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Zonisamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1737
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium sporogenes co-metabolize the drug Zonisamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[136], [137] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Clostridium symbiosum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Coprococcus comes co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Dorea formicigenerans co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nefazodone |
Click to Show/Hide the Detail |
| Drug ID |
DR1135
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Nefazodone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster asparagiformis co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[109], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterocloster bolteae co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Enterococcus casseliflavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus casseliflavus co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [138] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[110], [126] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus faecalis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Enterococcus gallinarum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterococcus gallinarum co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [138] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Methoxsalen |
Click to Show/Hide the Detail |
| Drug ID |
DR1047
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Methoxsalen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Erysipelatoclostridium ramosum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Eubacterium cellulosolvens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0077922 |
Click to Show/Hide the Detail |
| Drug ID |
DR0786
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium cellulosolvens co-metabolize the drug BRN-0077922, which can collectively affect efficacy, safety or bioavailability of this drug. |
[139], [140] |
| Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [14] |
| Eubacterium oxidoreducens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium oxidoreducens co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[131], [132] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium rectale co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Eubacterium ventriosum co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[45], [75] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 24 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Budesonide |
Click to Show/Hide the Detail |
| Drug ID |
DR0239
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Budesonide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Celecoxib |
Click to Show/Hide the Detail |
| Drug ID |
DR0286
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Celecoxib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[135], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [2] |
| Drospirenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0551
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Drospirenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [2] |
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [2] |
| Indapamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0868
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Indapamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[127], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Oxybutynin chloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1219
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Oxybutynin chloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Holdemanella biformis co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Hungatella hathewayi co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Lactobacillus crispatus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tenofovir alafenamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1552
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus crispatus co-metabolize the drug Tenofovir alafenamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [37] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Ergonovine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0598
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Ergonovine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus reuteri co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[45], [75] |
| Lactobacillus sakei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Erythromycin stearate |
Click to Show/Hide the Detail |
| Drug ID |
DR0614
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactobacillus sakei co-metabolize the drug Erythromycin stearate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[141], [142], [143] |
| Lactococcus lactis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Lactococcus lactis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [144] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Marvinbryantia formatexigens co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Mediterraneibacter glycyrrhizinilyticus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0077922 |
Click to Show/Hide the Detail |
| Drug ID |
DR0786
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Mediterraneibacter glycyrrhizinilyticus co-metabolize the drug BRN-0077922, which can collectively affect efficacy, safety or bioavailability of this drug. |
[139], [145] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 15 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mefloquine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1016
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Mefloquine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Roseburia intestinalis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[45], [75] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Levonorgestrel |
Click to Show/Hide the Detail |
| Drug ID |
DR0946
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Levonorgestrel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[62], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus gnavus co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Eszopiclone |
Click to Show/Hide the Detail |
| Drug ID |
DR0652
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus lactaris co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Ruminococcus torques co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Streptococcus agalactiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Irinotecan hydrochloride, and Streptococcus agalactiae further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[98], [133] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Subdoligranulum variabile co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Bacteria: Fusobacteria |
|---|
| Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [14] |
| Bacteria: Lentisphaerae |
|---|
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Deflazacort |
Click to Show/Hide the Detail |
| Drug ID |
DR0430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Deflazacort, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [2] |
| Famciclovir |
Click to Show/Hide the Detail |
| Drug ID |
DR0679
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Famciclovir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Victivallis vadensis co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteria: Proteobacteria |
|---|
| Acidovorax ebreus (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Cefalexin |
Click to Show/Hide the Detail |
| Drug ID |
DR0284
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Acidovorax ebreus co-metabolize the drug Cefalexin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[146], [147] |
| Acinetobacter baumannii (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pyrazinamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Acinetobacter baumannii co-metabolize the drug Pyrazinamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[148], [149] |
| Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[110], [126] |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clindamycin |
Click to Show/Hide the Detail |
| Drug ID |
DR0340
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Clindamycin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[87], [150] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paliperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1230
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Paliperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Risperidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1428
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Risperidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cancerogenus co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Enterobacter cloacae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cloacae co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [151] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Enterobacter cloacae co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [151] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 29 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[110], [126] |
| AN-16649 |
Click to Show/Hide the Detail |
| Drug ID |
DR0173
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug AN-16649, which can collectively affect efficacy, safety or bioavailability of this drug. |
[152], [153] |
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Betamethasone valerate |
Click to Show/Hide the Detail |
| Drug ID |
DR2381
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Betamethasone valerate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Clonazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0351
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Clonazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[154], [155] |
| Conjugated estrogens |
Click to Show/Hide the Detail |
| Drug ID |
DR0377
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Conjugated estrogens, which can collectively affect efficacy, safety or bioavailability of this drug. |
[156], [157] |
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [158] |
| Flunitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0712
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[159], [160] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Irinotecan hydrochloride, and Escherichia coli further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[98], [161] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Irinotecan hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[98], [161] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [162] |
| Mefloquine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1016
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Mefloquine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Megestrol acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1017
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Megestrol acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[19], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR1166
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Nitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[105], [163], [164] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Norgestimate |
Click to Show/Hide the Detail |
| Drug ID |
DR1178
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Norgestimate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[83], [2] |
| Sulfinpyrazone |
Click to Show/Hide the Detail |
| Drug ID |
DR1515
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Sulfinpyrazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| VUFB-11502 |
Click to Show/Hide the Detail |
| Drug ID |
DR2704
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug VUFB-11502, which can collectively affect efficacy, safety or bioavailability of this drug. |
[165], [166] |
| Ziprasidone |
Click to Show/Hide the Detail |
| Drug ID |
DR1732
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Escherichia coli co-metabolize the drug Ziprasidone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[60], [2] |
| Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Aztreonam |
Click to Show/Hide the Detail |
| Drug ID |
DR0169
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Klebsiella pneumoniae co-metabolize the drug Aztreonam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[167], [168] |
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Klebsiella pneumoniae co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [158] |
| Klebsiella variicola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aztreonam |
Click to Show/Hide the Detail |
| Drug ID |
DR0169
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Klebsiella variicola co-metabolize the drug Aztreonam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[167], [169] |
| Neisseria sicca (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ethanol |
Click to Show/Hide the Detail |
| Drug ID |
DR0655
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Neisseria sicca co-metabolize the drug Ethanol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [170] |
| Novosphingobium aromaticivorans (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Conjugated estrogens |
Click to Show/Hide the Detail |
| Drug ID |
DR0377
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Novosphingobium aromaticivorans co-metabolize the drug Conjugated estrogens, which can collectively affect efficacy, safety or bioavailability of this drug. |
[156], [171] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fenofibrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0688
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Fenofibrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Mefloquine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1016
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Mefloquine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia alcalifaciens co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Loperamide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0974
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Loperamide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[57], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia rettgeri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pseudomonas aeruginosa (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Pseudomonas aeruginosa co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [172] |
| Pseudomonas fluorescens (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Pseudomonas fluorescens co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [172] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[173], [174] |
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Pseudomonas putida co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [172] |
| Raoultella planticola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Raoultella planticola co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[53], [158] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Nitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR1166
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Nitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[105], [175] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[131], [175] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella enterica co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Salmonella typhimurium (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR1166
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Salmonella typhimurium co-metabolize the drug Nitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[105], [176], [177] |
| Shewanella oneidensis (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Shewanella oneidensis co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[178], [179], [180] |
| Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ibuprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0844
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[181], [182] |
| Wolinella succinogenes (epsilon-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Hydroquinone |
Click to Show/Hide the Detail |
| Drug ID |
DR0835
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Wolinella succinogenes co-metabolize the drug Hydroquinone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[183], [184] |
| Bacteria: Synergistetes |
|---|
| Synergistetes bacterium (synergistetes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Synergistetes bacterium co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[178], [185], [186] |
| Bacteria: Tenericutes |
|---|
| Mycoplasma hyorhinis (mycoplasmas) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Cytarabine |
Click to Show/Hide the Detail |
| Drug ID |
DR0398
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Mycoplasma hyorhinis co-metabolize the drug Cytarabine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[187], [188] |
| Bacteria: Verrucomicrobia |
|---|
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Artemisinin |
Click to Show/Hide the Detail |
| Drug ID |
DR0141
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Artemisinin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bromocriptine mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0233
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Bromocriptine mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Itraconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR0895
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Itraconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[97], [2] |
| Mycophenolate mofetil |
Click to Show/Hide the Detail |
| Drug ID |
DR1118
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Mycophenolate mofetil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[109], [2] |
| Tacrolimus |
Click to Show/Hide the Detail |
| Drug ID |
DR1524
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Tacrolimus, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Tinidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1596
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Tinidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Trimebutine |
Click to Show/Hide the Detail |
| Drug ID |
DR1646
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Akkermansia muciniphila co-metabolize the drug Trimebutine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Fungi: Ascomycota |
|---|
| Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[110], [126] |
| Archaea: Euryarchaeota |
|---|
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [189] |
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanobrevibacter oralis co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [189] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [189] |
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanobrevibacter smithii co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [189] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [189] |
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanomassiliicoccus luminyensis co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [189] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [189] |
| Tetracycline |
Click to Show/Hide the Detail |
| Drug ID |
DR1568
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Methanosphaera stadtmanae co-metabolize the drug Tetracycline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[107], [189] |
| Amoebozoa: Evosea |
|---|
| Entamoeba histolytica (eukaryotes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Entamoeba histolytica co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [190] |
| Metamonada: Fornicata |
|---|
| Giardia intestinalis (diplomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Giardia intestinalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [190] |
| Metamonada: Parabasalia |
|---|
| Trichomonas vaginalis (trichomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A4 (CYP3A4) and Trichomonas vaginalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[90], [190] |
|
|
|
|
|
|
